Arrowhead Research | ARWR - القيمة السوقية





القيمة السوقية تغيير تاريخ
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 10.84B 664M 2026-08
Heron Therapeutics USD 238M 7M 2025-12
Incyte USD 26.84B 4.19B 2026-08
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Ligand Pharmaceuticals USD 5.31B 1.02B 2026-08
Merck USD 324.18B 6.81B 2026-08
Nektar Therapeutics USD 12.98B 10.86B 2026-08
Novartis USD 240.59B 67.17B 2026-06
Sarepta Therapeutics USD 1.5B 402M 2026-08
TG Therapeutics USD 7.63B 778M 2026-08
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
Vertex Pharmaceuticals USD 137.33B 11.26B 2026-08
Xencor USD 1.21B 19M 2026-08